![](https://i0.wp.com/www.mind.uci.edu/wp-content/uploads/2018/07/merlin_136623828_e67c54ac-ec63-419e-845b-0e8af84a9f56-superJumbo-300x200.jpg?resize=300%2C200&ssl=1)
Photo credit: Zack Wittman for The New York Times
The New York Times recently covered a new clinical trial effort Eli Lilly is undertaking, the TRAILBLAZER-ALZ clinical research study. The study, which UCI MIND investigators are participating in, aims to enroll 375 people with early Alzheimer’s disease. To learn more about the TRAILBLAZER-ALZ study, click here, or contact us at research@mind.uci.edu or call 949.824.0008.